Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.495, 2006-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA advises of risk factor for PML, gives go ahead for test
Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. :
Access to resources
Recommend
US FDA advises caution for recombinant erythropoietins
Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. :
US FDA advises caution for recombinant erythropoietins
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
US Task Force advises against use of HRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. :
US FDA panel advises banning of two asthma drugs
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :